Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares U.S. Pharmaceutical ETF (NY:IHE)

75.97 +0.71 (+0.94%)
Official Closing Price Updated: 8:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 104,262
Open 75.00
Bid (Size) 72.25 (1)
Ask (Size) 80.34 (1)
Prev. Close 75.26
Today's Range 74.93 - 76.13
52wk Range 58.97 - 76.14
Shares Outstanding 82,000
Dividend Yield 1.64%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush. 
Via Benzinga
Topics ETFs
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk
The U.S. pharmaceutical industry is at the center of a policy maelstrom. 
Via Benzinga
Topics ETFs

Performance

YTD
+15.8%
+15.8%
1 Month
+1.3%
+1.3%
3 Month
+13.7%
+13.7%
6 Month
+13.7%
+13.7%
1 Year
+10.0%
+10.0%

More News

Read More
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms
Via Benzinga
Topics Government World Trade
White House Clarifies Recent Pharmaceutical Tariffs Exempt Countries with Trade Agreements: Report
Via Stocktwits
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing
Via Benzinga
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
Via Benzinga
Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'
Via Benzinga
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills
Via Benzinga
Topics Artificial Intelligence ETFs
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
Via Benzinga
Topics Government World Trade
FDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: Report
Via Stocktwits
Topics Government
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Via Benzinga
Topics Government World Trade
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Via Benzinga
FDA Aims To Reduce Drug Application Review Time With New Voucher Program
Via Stocktwits
Robert Kennedy Jr Axes Entire CDC Vaccine Panel To 'Restore Public Trust' — Pfizer, Moderna, Other Biotech Stocks Drop In After-Hours Trading
Via Benzinga
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Via Benzinga
Topics Government
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Via Benzinga
Topics Government
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks
Via Benzinga
Topics ETFs Government
Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report
Via Stocktwits
Topics Government Intellectual Property Lawsuit
Trump Administration Considers Lowering US Drug Prices To International Levels: Report
Via Benzinga
Topics Government
ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot
Via Benzinga
Topics ETFs
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Via Benzinga
Topics Government World Trade
Biopharma: A 'Safe Haven' As Tariff Turmoil Rages On?
Via Benzinga
Topics World Trade
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
Via Benzinga
Topics ETFs Government World Trade
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
Via Benzinga
US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget
Via Benzinga

Frequently Asked Questions

Is iShares U.S. Pharmaceutical ETF publicly traded?
Yes, iShares U.S. Pharmaceutical ETF is publicly traded.
What exchange does iShares U.S. Pharmaceutical ETF trade on?
iShares U.S. Pharmaceutical ETF trades on the New York Stock Exchange
What is the ticker symbol for iShares U.S. Pharmaceutical ETF?
The ticker symbol for iShares U.S. Pharmaceutical ETF is IHE on the New York Stock Exchange
What is the current price of iShares U.S. Pharmaceutical ETF?
The current price of iShares U.S. Pharmaceutical ETF is 75.97
When was iShares U.S. Pharmaceutical ETF last traded?
The last trade of iShares U.S. Pharmaceutical ETF was at 10/31/25 08:00 PM ET
What is the market capitalization of iShares U.S. Pharmaceutical ETF?
The market capitalization of iShares U.S. Pharmaceutical ETF is 6.23M
How many shares of iShares U.S. Pharmaceutical ETF are outstanding?
iShares U.S. Pharmaceutical ETF has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.